Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alice J Chen

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Journal of Health Economics|December 24, 2011
When does weight matter most?Alice J Chen
Journal of Health Economics|September 15, 2024
Paying for advance care planning in medicare: Impacts on care and spending near end of lifeAlice J Chen, Jing Li
American Journal of Health Economics|September 2, 2025
How Benchmark Changes Affect Participation in Accountable Care Organizations: Prospects for Voluntary Payment ModelsAlice J Chen, J Michael McWilliams
JAMA Internal Medicine|December 7, 2020
Variation in Biosimilar Uptake in Europe-ReplyAlice J Chen, Karen Van Nuys
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 13, 2018
Productivity Benefits of Medical Care: Evidence from US-Based Randomized Clinical TrialsAlice J Chen, Dana P Goldman
The American Journal of Managed Care|May 22, 2020
Provider differences in biosimilar uptake in the filgrastim marketAlice J Chen, Rocio Ribero, Karen Van Nuys
Health Services Research|June 17, 2024
Fitting in? Physician practice style after forced relocationAlice J Chen, Michael R Richards, Rachel Shriver
Health Affairs (Project Hope)|May 3, 2021
Spending On Targeted Therapies Reduced Mortality In Patients With Advanced-Stage Breast CancerMeng Li, Dana P Goldman, Alice J Chen
JAMA Internal Medicine|July 24, 2020
Uptake of Infliximab Biosimilars Among the Medicare PopulationAlice J Chen, Laura Gascue, Rocio Ribero, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 28, 2022
Value of Reducing Wait Times for Chimeric Antigen Receptor T-Cell Treatment: Evidence From Randomized Controlled Trial Data on Tisagenlecleucel for Diffuse Large B-Cell LymphomaAlice J Chen, Jie Zhang, Abhijit Agarwal, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Journal of Health Economics|December 24, 2011
When does weight matter most?Alice J Chen
Journal of Health Economics|September 15, 2024
Paying for advance care planning in medicare: Impacts on care and spending near end of lifeAlice J Chen, Jing Li
American Journal of Health Economics|September 2, 2025
How Benchmark Changes Affect Participation in Accountable Care Organizations: Prospects for Voluntary Payment ModelsAlice J Chen, J Michael McWilliams
JAMA Internal Medicine|December 7, 2020
Variation in Biosimilar Uptake in Europe-ReplyAlice J Chen, Karen Van Nuys
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 13, 2018
Productivity Benefits of Medical Care: Evidence from US-Based Randomized Clinical TrialsAlice J Chen, Dana P Goldman
The American Journal of Managed Care|May 22, 2020
Provider differences in biosimilar uptake in the filgrastim marketAlice J Chen, Rocio Ribero, Karen Van Nuys
Health Services Research|June 17, 2024
Fitting in? Physician practice style after forced relocationAlice J Chen, Michael R Richards, Rachel Shriver
Health Affairs (Project Hope)|May 3, 2021
Spending On Targeted Therapies Reduced Mortality In Patients With Advanced-Stage Breast CancerMeng Li, Dana P Goldman, Alice J Chen
JAMA Internal Medicine|July 24, 2020
Uptake of Infliximab Biosimilars Among the Medicare PopulationAlice J Chen, Laura Gascue, Rocio Ribero, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 28, 2022
Value of Reducing Wait Times for Chimeric Antigen Receptor T-Cell Treatment: Evidence From Randomized Controlled Trial Data on Tisagenlecleucel for Diffuse Large B-Cell LymphomaAlice J Chen, Jie Zhang, Abhijit Agarwal, et al.
Pageof 3